Tumor-informed circulating tumor DNA detection for personalized monitoring of treatment response in epithelial ovarian cancer
This study demonstrates the clinical utility of ddPCR for monitoring treatment responses in EOC by targeting patient-specific mutations. Integrating ddPCR with NGS-based mutation identification offers an effective approach for assessing therapeutic outcomes in EOC patients.
Authors
- Shin‐Wha Lee (ORCID: https://orcid.org/0000-0002-5088-1905)
- M. G. Lee
- Ok-Ju Kang (ORCID: https://orcid.org/0000-0002-4574-5124)
- Sung Wan Kang (ORCID: https://orcid.org/0000-0002-7360-8311)
- Ji Young Lee (ORCID: https://orcid.org/0000-0002-6102-0510)
- Young-Jae Lee (ORCID: https://orcid.org/0000-0001-6557-2454)
- Yong‐Man Kim (ORCID: https://orcid.org/0000-0003-3391-4426)
- Hee Jung Jung
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- Korea Institute of Radiological and Medical Sciences (KR)
- Gangneung Asan Hospital (KR)
Publication Details
- Journal
- Practical Laboratory Medicine
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1016/j.plabm.2025.e00500
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation of Korea
- Asan Institute for Life Sciences, Asan Medical Center
- Ministry of Science and ICT, South Korea